1. Home
  2. MKTX vs MMED Comparison

MKTX vs MMED Comparison

Compare MKTX & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketAxess Holdings Inc.

MKTX

MarketAxess Holdings Inc.

N/A

Current Price

$115.37

Market Cap

4.6B

Sector

Finance

ML Signal

N/A

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$14.64

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MKTX
MMED
Founded
2000
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.1B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
MKTX
MMED
Price
$115.37
$14.64
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$204.88
$22.56
AVG Volume (30 Days)
611.1K
818.9K
Earning Date
05-07-2026
06-03-2026
Dividend Yield
1.94%
N/A
EPS Growth
N/A
N/A
EPS
2.20
N/A
Revenue
$397,471,000.00
N/A
Revenue This Year
$10.14
$15.99
Revenue Next Year
$7.22
$10.00
P/E Ratio
$53.15
N/A
Revenue Growth
7.45
N/A
52 Week Low
$115.55
$10.65
52 Week High
$228.16
$17.86

Technical Indicators

Market Signals
Indicator
MKTX
MMED
Relative Strength Index (RSI) 14.41 66.27
Support Level N/A $12.80
Resistance Level $177.51 $15.80
Average True Range (ATR) 3.90 0.86
MACD -0.99 0.46
Stochastic Oscillator 6.48 84.58

Price Performance

Historical Comparison
MKTX
MMED

About MKTX MarketAxess Holdings Inc.

Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: